Cargando…

Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma

Background. Carcinomas of the breast with neuroendocrine features are incorporated in the World Health Organization classification since 2003 and include well-differentiated neuroendocrine tumors, poorly differentiated neuroendocrine carcinomas/small cell carcinomas, and invasive breast carcinomas w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wachter, David L., Hartmann, Arndt, Beckmann, Matthias W., Fasching, Peter A., Hein, Alexander, Bayer, Christian M., Agaimy, Abbas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950407/ https://www.ncbi.nlm.nih.gov/pubmed/24701575 http://dx.doi.org/10.1155/2014/408459

Ejemplares similares

Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis
por: Schulmeyer, Carla E., et al.
Publicado: (2023)

Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
por: Erber, Ramona, et al.
Publicado: (2021)

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
por: Fasching, Peter A, et al.
Publicado: (2011)

Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection
por: Schrauder, Michael G., et al.
Publicado: (2012)

Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
por: Hein, Alexander, et al.
Publicado: (2014)

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
por: Gass, Paul, et al.
Publicado: (2018)

SMARCB1(INI1)-deficient Sinonasal Basaloid Carcinoma: A Novel Member of the Expanding Family of SMARCB1-deficient Neoplasms
por: Agaimy, Abbas, et al.
Publicado: (2014)

YAP1-MAML2-Rearranged Poroid Squamous Cell Carcinoma (Squamoid Porocarcinoma) Presenting as a Primary Parotid Gland Tumor
por: Agaimy, Abbas, et al.
Publicado: (2020)

Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS)
por: Gebrekidan, Medhanie Tesfay, et al.
Publicado: (2018)

Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
por: Burghaus, Stefanie, et al.
Publicado: (2015)

Molecular Subtypes of Extra-pulmonary Neuroendocrine Carcinomas Identified by the Expression of Neuroendocrine Lineage-Specific Transcription Factors
por: Metovic, Jasna, et al.
Publicado: (2022)

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer
por: Bektas, Nuran, et al.
Publicado: (2008)

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy
por: Büttner, Florian A., et al.
Publicado: (2022)

NSD3-NUTM1-rearranged carcinoma of the median neck/thyroid bed developing after recent thyroidectomy for sclerosing mucoepidermoid carcinoma with eosinophilia: report of an extraordinary case
por: Agaimy, Abbas, et al.
Publicado: (2021)

Prominent entrapment of respiratory epithelium in primary and metastatic intrapulmonary non-epithelial neoplasms: a frequent morphological pattern closely mimicking adenofibroma and other biphasic pulmonary lesions
por: Erber, Ramona, et al.
Publicado: (2020)

Undifferentiated large cell/rhabdoid carcinoma presenting in the intestines of patients with concurrent or recent non-small cell lung cancer (NSCLC): clinicopathologic and molecular analysis of 14 cases indicates an unusual pattern of dedifferentiated metastases
por: Agaimy, Abbas, et al.
Publicado: (2021)

Targeted sequencing of FH-deficient uterine leiomyomas reveals biallelic inactivating somatic fumarase variants and allows characterization of missense variants
por: Popp, Bernt, et al.
Publicado: (2020)

Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-World Setting
por: Erber, Ramona, et al.
Publicado: (2022)

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
por: Büttner, Florian, et al.
Publicado: (2018)

Breast carcinoma: molecular markers and subtypes to predict patients at risk of developing metastatic disease
por: Inderhaug, CR, et al.
Publicado: (2009)

Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians
por: Gass, Paul, et al.
Publicado: (2018)

DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2016)

Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
por: Erber, Ramona, et al.
Publicado: (2020)

Towards a Molecular Classification of Sinonasal Carcinomas: Clinical Implications and Opportunities
por: Taverna, Cecilia, et al.
Publicado: (2022)

Renal neuroendocrine tumors: clinical and molecular pathology with an emphasis on frequent association with ectopic Cushing syndrome
por: Kasajima, Atsuko, et al.
Publicado: (2023)

HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
por: Wuerfel, Franziska M., et al.
Publicado: (2020)

Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer
por: Krumbholz, Manuela, et al.
Publicado: (2019)

Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria
por: Hoyer, Juliane, et al.
Publicado: (2018)

Mammographic density and prognosis in primary breast cancer patients
por: Heindl, Felix, et al.
Publicado: (2021)

Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
por: Pöschke, Patrik, et al.
Publicado: (2023)

Pancreatic panniculitis in a patient with pancreatic-type acinar cell carcinoma of the liver – case report and review of literature
por: Zundler, Sebastian, et al.
Publicado: (2016)

Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?
por: Frizziero, Melissa, et al.
Publicado: (2021)

SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report
por: Gerber, Tiemo S., et al.
Publicado: (2021)

Neuroendocrine breast carcinomas of aged women may express apocrine differentiation markers
por: Sapino, A, et al.
Publicado: (2001)

Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma
por: Monteiro, Ana Carolina, et al.
Publicado: (2019)

Primary neuroendocrine carcinoma of breast
por: Singh, Sunita, et al.
Publicado: (2011)

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
por: George, Julie, et al.
Publicado: (2018)

Classification of colorectal carcinoma subtypes based on ferroptosis-associated molecular markers
por: Yue, Qingfang, et al.
Publicado: (2022)

Evaluation of neuroendocrine markers in renal cell carcinoma
por: Ronkainen, Hanna, et al.
Publicado: (2010)

Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic Implications
por: Simbolo, Michele, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uu23t6eqnpurq7f9adt5k8fasp